Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact
Drug Formulation | Whitepapers & Reports

Solution Engine 2.0: Rapid Formulation Development of Amorphous Solid Dispersions by Combined In-Silico Modelling, High-Throughput Screening and in-vivo PK Study

24 May 2023
Amorphous solid dispersion (ASD) technology has been successfully utilized to enhance solubility and bioavailability of poorly soluble APIs.
Open document in a new tab

Related Resources

The Roadmap of ADC Formulation & Delivery: Achievements and Obstacles

Dive into the progress and challenges in Antibody-Drug Conjugates formulation and delivery for cancer treatment. We emphasize the advancements in targeting precision and efficacy, while discussing key development challenges like target selection, drug potency, and manufacturing complexities in this evolving oncology field.
Read More

Kurma Partners to Collaborate with Samsung Biologics for the Development and Manufacture of Biologics Drugs

Samsung Biologics will develop and manufacture drugs for Kurma’s portfolio companies, including by providing CMC drug development.
Read More

Related Online Activities

Join the conversation with our upcoming Monthly Science Exchanges and Webinars:
02/05/24
Inhaled Biologics Formulation
03/06/24
Controlled Release Formulations